Svas Biosana S.p.A. Share Price
Equities
SVS
IT0005469264
Medical Equipment, Supplies & Distribution
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 EUR | -.--% | -.--% | +1.25% |
01/05 | Svas Biosana S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
16/04 | Svas Biosana increases profit in 2023; ex-dividend proposed | AN |
Sales 2023 | 118M 126M 10.55B | Sales 2024 * | 124M 132M 11.02B | Capitalization | 43.73M 46.76M 3.9B |
---|---|---|---|---|---|
Net income 2023 | 5M 5.35M 446M | Net income 2024 * | 6M 6.42M 535M | EV / Sales 2023 | 0.37 x |
Net Debt 2023 * | 27.1M 28.98M 2.42B | Net Debt 2024 * | 27.4M 29.3M 2.44B | EV / Sales 2024 * | 0.58 x |
P/E ratio 2023 * |
9.31
x | P/E ratio 2024 * |
7.17
x | Employees | 374 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 31.42% |
Current month | -3.34% | ||
1 month | -3.34% | ||
3 months | +9.76% | ||
6 months | +13.45% | ||
Current year | +1.25% |
Managers | Title | Age | Since |
---|---|---|---|
Umberto Perillo
CEO | Chief Executive Officer | 63 | 28/12/28 |
Andrea Efficace
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 30/15/30 | |
Umberto Perillo
CEO | Chief Executive Officer | 63 | 28/12/28 |
Chairman | 74 | 28/12/28 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 8.1 | -.--% | 340 |
29/24/29 | 8.1 | -1.82% | 3,341 |
26/24/26 | 8.25 | +0.61% | 1,560 |
25/24/25 | 8.2 | -.--% | 0 |
24/24/24 | 8.2 | -.--% | 604 |
Real-time Borsa Italiana, April 30, 2024 at 09:14 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.25% | 46.7M | |
-4.26% | 184B | |
-1.72% | 107B | |
-2.47% | 67.52B | |
+0.73% | 50.06B | |
+10.15% | 45.67B | |
+3.40% | 41B | |
+2.66% | 26.73B | |
+3.63% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- SVS Stock